Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cellectar Biosc (NQ: CLRB )

1.300 USD -0.010 (-0.76%)
Streaming Delayed Price Updated: 10:09 AM EDT, Jun 18, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 45,950
Open 1.310
Bid (Size) 1.300 (54)
Ask (Size) 1.310 (10)
Prev. Close 1.310
Today's Range 1.300 - 1.330
52wk Range 1.010 - 2.980
Shares Outstanding 52,726,278
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cellectar Presents Data in Waldenstrom’s Macroglobulinemia in Poster at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
From GlobeNewswire News Releases
Cellectar Announces Poster Presentation of CLR 131 Data in Waldenstrom’s Macroglobulinemia at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Management to host a KOL call with Dr. Sikandar Ailawadhi, M.D., lead investigator on June 4 at 10:00 am 
From GlobeNewswire News Releases

Performance

YTD
-37.20%
-37.20%
1 Month
-13.33%
-13.33%
3 Month
-32.29%
-32.29%
6 Month
-38.68%
-38.68%
1 Year
+9.24%
+9.24%

More News

Read More
Cellectar to Participate at the Oppenheimer Rare & Orphan Disease Summit on May 21, 2021
From GlobeNewswire News Releases
Cellectar Reports Financial Results for the First Quarter 2021 and Provides a Corporate Update
From GlobeNewswire News Releases
Cellectar Strengthens Global IP Position with Phospholipid Drug Conjugate Composition of Matter Patent in Eurasia, Australia, and Mexico
From GlobeNewswire News Releases
Cellectar to Participate at Upcoming Institutional Investor Conferences
From GlobeNewswire News Releases
Cellectar Granted Japanese Composition of Matter Patent for its Phospholipid-Ether Drug Conjugates
From GlobeNewswire News Releases
Cellectar to Participate at Upcoming Institutional Investor Conferences
From GlobeNewswire News Releases
Cellectar Bio Stock Drops After ASCO Presentation on White Blood Cell Cancer Therapy
Tags News FDA Health Care
From Benzinga
Cellectar Reports Financial Results for Year Ended December 31, 2020 and Provides a Corporate Update
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Friday's Intraday Session
Tags Benzinga WINT PSTI
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.